What is a suitable intravenous (IV) fluid to administer to a patient, and is a D5 (5% dextrose) containing solution necessary?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Fluid Selection for Hospital Admission

For most hospitalized patients requiring IV fluids, use isotonic balanced crystalloid solutions (such as Ringer's Lactate or Plasmalyte) without dextrose as your first-line choice, as they reduce the risk of kidney injury and mortality compared to normal saline, while avoiding unnecessary hyperglycemia. 1

Primary Fluid Choice: Balanced Crystalloids

Balanced crystalloid solutions (Ringer's Lactate or Plasmalyte) are preferred over 0.9% normal saline because they reduce major adverse kidney events and maintain better acid-base balance, particularly when larger volumes (>5000 mL) are administered. 1

  • The SMART study of 15,802 ICU patients demonstrated reduced incidence of major adverse kidney events (MAKE 30: death, two-fold increase in serum creatinine, or renal replacement therapy within 30 days) with balanced solutions compared to normal saline. 1

  • High-volume chloride-rich solutions (>5000 mL) are associated with increased mortality and postoperative hyperchloremia in critically ill patients. 1

  • Balanced solutions consistently provide better acid-base balance than normal saline across all patient populations. 1

When to Add Dextrose (D5)

Most adult patients do NOT require dextrose-containing fluids initially. The decision to add dextrose depends on specific clinical scenarios:

DO NOT use dextrose-containing fluids for:

  • Routine volume resuscitation or maintenance in adults - A study of 50 non-diabetic surgical patients showed that 500 mL of D5 normal saline caused significant hyperglycemia (plasma glucose 11.1 mmol/L) in 72% of patients, while those receiving non-dextrose crystalloids remained normoglycemic despite fasting times of 13 hours. 2

  • Initial fluid resuscitation in most hospitalized adults - Dextrose is unnecessary to prevent hypoglycemia in fasting adults and causes transient but significant hyperglycemia even in non-diabetic patients. 2

DO use dextrose-containing fluids for:

  • Pediatric patients (28 days to 18 years) requiring maintenance IV fluids should receive isotonic solutions with appropriate potassium chloride AND dextrose (2.5%-5%) to prevent hypoglycemia. 1

  • Diabetic ketoacidosis (DKA) - Switch to D5 with 0.45-0.75% saline when serum glucose reaches 250 mg/dL to prevent hypoglycemia while continuing insulin therapy. 3

  • Infants at risk for hypoglycemia - Use D10 normal saline to meet glucose requirements of 4-6 mg/kg/min in infants dependent on IV fluids. 3

  • Hypernatremic dehydration - Use 5% dextrose alone (without sodium) for gradual correction to prevent worsening hypernatremia. 3

  • Medication diluent - D5 solutions serve as vehicles for specific medications like vasopressors, ranitidine, or quinine, though glucose content must be considered in diabetic patients. 4, 5

Practical Algorithm for Fluid Selection

Step 1: Determine if dextrose is needed

  • Adult, non-diabetic, routine admission? → No dextrose needed 2
  • Pediatric patient (28 days-18 years)? → Yes, add dextrose 2.5-5% 1
  • DKA with glucose <250 mg/dL? → Yes, switch to D5 3
  • Infant at hypoglycemia risk? → Yes, use D10 3
  • Hypernatremia? → Yes, use D5 alone (no sodium) 3

Step 2: Choose base crystalloid solution

  • First-line: Balanced crystalloid (Ringer's Lactate or Plasmalyte) 1
  • Avoid: Normal saline as routine first-line (use only when balanced solutions unavailable) 1
  • Never use: Hypertonic saline (3% or 7.5%) for routine resuscitation 1

Step 3: Avoid colloids in most situations

  • Do not use hydroxyethyl starch solutions - they increase renal failure risk and hemorrhagic complications. 1
  • Do not routinely use albumin for volume resuscitation - no mortality benefit and significantly more expensive than crystalloids. 1

Critical Monitoring Considerations

When dextrose-containing fluids ARE used:

  • Monitor serum glucose hourly during acute resuscitation, then every 2-4 hours once stable to prevent both hyperglycemia and hypoglycemia. 3

  • Be aware that 50% dextrose is hypertonic and may cause phlebitis, thrombosis, hyperosmolar syndrome, and fluid overload - it should only be used via central venous access after suitable dilution. 6

  • In pediatric patients, monitor for cerebral edema during osmolality correction, particularly in those under 20 years. 3

Common Pitfalls to Avoid

  • Do not assume fasting adults need dextrose - even after 13 hours of fasting, non-diabetic adults remain normoglycemic without dextrose supplementation. 2

  • Do not use normal saline as default - the outdated practice of routine normal saline administration increases hyperchloremic metabolic acidosis and kidney injury risk. 1, 7

  • Do not give large volumes of any single fluid without reassessment - both inadequate and excessive fluid administration lead to poor outcomes including increased infection risk and organ dysfunction. 8

  • Do not use colloids for routine resuscitation - they offer no mortality benefit over crystalloids and carry additional risks of renal impairment and coagulopathy. 1, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

D5 1/2 Normal Saline Infusion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dextrose Content in IV Fluids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Use of 5% Dextrose as a Diluent in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Are we close to the ideal intravenous fluid?

British journal of anaesthesia, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.